Yagi, S.; Fukui, H.; Ikenouchi, M.; Shiraishi, T.; Kaku, K.; Wakita, M.; Takagi, Y.; Sato, T.; Kawai, M.; Kamikozuru, K.;
et al. Continuous Treatment with Tofacitinib but Not Filgotinib Is Effective in Non-Responders with Active Ulcerative Colitis: A Propensity Score-Matching Analysis. J. Clin. Med. 2025, 14, 217.
https://doi.org/10.3390/jcm14010217
AMA Style
Yagi S, Fukui H, Ikenouchi M, Shiraishi T, Kaku K, Wakita M, Takagi Y, Sato T, Kawai M, Kamikozuru K,
et al. Continuous Treatment with Tofacitinib but Not Filgotinib Is Effective in Non-Responders with Active Ulcerative Colitis: A Propensity Score-Matching Analysis. Journal of Clinical Medicine. 2025; 14(1):217.
https://doi.org/10.3390/jcm14010217
Chicago/Turabian Style
Yagi, Soichi, Hirokazu Fukui, Maiko Ikenouchi, Tetsuya Shiraishi, Koji Kaku, Midori Wakita, Yasuhiro Takagi, Toshiyuki Sato, Mikio Kawai, Koji Kamikozuru,
and et al. 2025. "Continuous Treatment with Tofacitinib but Not Filgotinib Is Effective in Non-Responders with Active Ulcerative Colitis: A Propensity Score-Matching Analysis" Journal of Clinical Medicine 14, no. 1: 217.
https://doi.org/10.3390/jcm14010217
APA Style
Yagi, S., Fukui, H., Ikenouchi, M., Shiraishi, T., Kaku, K., Wakita, M., Takagi, Y., Sato, T., Kawai, M., Kamikozuru, K., Yokoyama, Y., Takagawa, T., Tomita, T., & Shinzaki, S.
(2025). Continuous Treatment with Tofacitinib but Not Filgotinib Is Effective in Non-Responders with Active Ulcerative Colitis: A Propensity Score-Matching Analysis. Journal of Clinical Medicine, 14(1), 217.
https://doi.org/10.3390/jcm14010217
